Ophthalmology Doctors in Flint, MI Accepting Medicare

11 Ophthalmology doctors found. Showing 1 - 11

Dr. Steven Allen Boskovich, MD Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 1290 S Linden Rd, Flint, MI 48532 Phone: 810-732-6231    Fax: 810-732-0725

Dr. Aman Khaled Shukairy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1160 S Linden Rd, Flint, MI 48532 Phone: 810-820-8230    Fax: 810-820-8937

Dr. David A Diskin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111    Fax: 810-733-7141

John A Waters, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5055 W Bristol Rd, Flint, MI 48507 Phone: 810-732-2272    Fax: 810-732-8470

Dr. Jeffrey A Diskin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111    Fax: 810-733-7141

Dr. Gary M Keoleian, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111    Fax: 810-733-7141

Daniel Joseph Ryan, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1113 Villa Linde Ct, Flint, MI 48532 Phone: 810-733-1214    Fax: 810-733-3011

Robert Jay Zendler Ii, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1335 S Linden Rd, Suite E, Flint, MI 48532 Phone: 810-733-5535    Fax: 810-733-1076

Aleksey Mishulin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5300 Gateway Ctr, Flint, MI 48507 Phone: 810-720-9111    Fax: 810-720-9119

Edward P Stack, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5300 Gateway Ctr, Flint, MI 48507 Phone: 810-720-9111    Fax: 810-720-9119

Leroy Johnson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2900 N Saginaw St, Flint, MI 48505 Phone: 810-789-9141    Fax: 810-789-9222

News Archive

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.

AMA President: Alberta's health care system needs change

Alberta's health care system needs change, but change must be planned with proper consultation and true feedback from physicians, the public and other health professionals. This was the message of outgoing Alberta Medical Association (AMA) President Dr. Noel W. Grisdale.

Inflammation has a role to play in premature births and brain injury: Sahlgrenska Academy thesis

Researchers have gone some way to explaining what happens during premature births and how brain injury develops in premature babies. New findings show that inflammation in both the amniotic fluid and the baby's brain has a role to play, reveals a thesis from the Sahlgrenska Academy.

New study addresses general barriers inhibiting cancer research commercialization

A new study led by the University of Kentucky Markey Cancer Center Assistant Director for Research Nathan Vanderford cites a combination of factors that prevent academic-based cancer research faculty from ultimately commercializing their work.

Read more Medical News

› Verified 1 days ago